Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Benefits of equine analgesia
Road shows highlight major benefits

Equine analgesia was a key topic for discussion at a recent series of Equine Road Shows, where delegate opinions have been described as "overwhelmingly positive".

Over one hundred vets attended the events, which were organised by Alstoe Ltd, Bristol University and Langford Veterinary Services, and covered topics including anaesthesia, analgesia and equine surgery.

Opening the meetings, which took place in Hickstead, Newmarket and York, Dr Polly Taylor said: "Until recently, equine analgesia has been somewhat neglected.

"Although still lagging behind the progress in human medical practice and small animal veterinary care, the need for proper pain management in horses is now acknowledged."

Evidence suggests that profound analgesia in human surgery leads to better athletic performance in the following weeks and months. The same is suspected to apply to equine patients.

On the whole, feedback from delegates suggested that analgesia is vital in allowing concurrent treatment to work to its best advantage, by keeping the horse pain-free and therefore calm and interactive, with a good appetite.

One analgesic to be discussed was burprenorphine (vetergesic), which is very commonly used for small animals, but less so in horses.

Studies at Bristol University, however, have suggested that vetergesic has significantly better analgesic benefits than butorphanol.

Polly commented: "One of its major advantages is its ability to provide up to 12 hours of analgesia, giving it considerable potential as an analgesic in horses."

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.